Gene · 7706
Papers2,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 2,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Flaviviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines. | Front Immunol | 2022 | 35154151 | PubTator, text mining | PubMed |
| Early innate immune response triggered by the human respiratory syncytial virus and its regulation by ubiquitination/deubiquitination processes. | J Biomed Sci | 2022 | 35152905 | PubTator, text mining | PubMed |
| Regulation of antiviral innate immunity by chemical modification of viral RNA. | Wiley Interdiscip Rev RNA | 2022 | 35150188 | PubTator, text mining | PubMed |
| Comprehensive profiling of the TRIpartite motif family to identify pivot genes in hepatocellular carcinoma. | Cancer Med | 2022 | 35142083 | PubTator, text mining | PubMed |
| Novel insights into the interaction between N6-methyladenosine modification and circular RNA. | Mol Ther Nucleic Acids | 2022 | 35141044 | PubTator, text mining | PubMed |
| Distinct Cellular Tropism and Immune Responses to Alphavirus Infection. | Annu Rev Immunol | 2022 | 35134315 | PubTator, text mining | PubMed |
| The Slowing Rate of CpG Depletion in SARS-CoV-2 Genomes Is Consistent with Adaptations to the Human Host. | Mol Biol Evol | 2022 | 35134218 | PubTator, text mining | PubMed |
| Poly(ADP-ribose) potentiates ZAP antiviral activity. | PLoS Pathog | 2022 | 35130321 | PubTator, text mining | PubMed |
| The Emerging Roles of Circular RNAs in the Chemoresistance of Gastrointestinal Cancer. | Front Cell Dev Biol | 2022 | 35127685 | PubTator, text mining | PubMed |
| HBXIP is a novel regulator of the unfolded protein response that sustains tamoxifen resistance in ER+ breast cancer. | J Biol Chem | 2022 | 35093383 | PubTator, text mining | PubMed |
| Methionine oxidation of CLK4 promotes the metabolic switch and redox homeostasis in esophageal carcinoma via inhibiting MITF selective autophagy. | Clin Transl Med | 2022 | 35092699 | PubTator, text mining | PubMed |
| Protein phosphatase 1 regulatory inhibitor subunit 14C promotes triple-negative breast cancer progression via sustaining inactive glycogen synthase kinase 3 beta. | Clin Transl Med | 2022 | 35090098 | PubTator, text mining | PubMed |
| ATAD2 drives colorectal cancer progression by regulating TRIM25 expression via a positive feedback loop with E2F transcriptional factors. | Biochem Biophys Res Commun | 2022 | 35085891 | PubTator, text mining | PubMed |
Tumor Susceptibility Gene 101 (TSG101) Contributes to Virion Formation of Porcine Reproductive and Respiratory Syndrome Virus via Interaction with the Nucleocapsid (N) Protein along with the Early Secretory Pathway. | J Virol | 2022 | 35080428 | PubTator, text mining | PubMed |
| USP44 regulates irradiation-induced DNA double-strand break repair and suppresses tumorigenesis in nasopharyngeal carcinoma. | Nat Commun | 2022 | 35079021 | PubTator, text mining | PubMed |
| Viral Interference between Respiratory Viruses. | Emerg Infect Dis | 2022 | 35075991 | PubTator, text mining | PubMed |
| SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules. | Signal Transduct Target Ther | 2022 | 35075101 | PubTator, text mining | PubMed |
| Immunoediting in SARS-CoV-2: Mutual relationship between the virus and the host. | Int Immunopharmacol | 2022 | 35074569 | PubTator, text mining | PubMed |
| Mitochondria and Viral Infection: Advances and Emerging Battlefronts. | mBio | 2022 | 35073751 | PubTator, text mining | PubMed |
| Novel γ-sarcoglycan interactors in murine muscle membranes. | Skelet Muscle | 2022 | 35065666 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7706/papers?page=49